Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐HRpQCT Study
暂无分享,去创建一个
M. Bouxsein | Hang Lee | R. Neer | N. Derrico | J. Tsai | A. Uihlein | B. Leder | S. M. Burnett-Bowie | Mary L Bouxsein | Hang Lee | Joy N Tsai | Alexander V Uihlein | Sherri-Ann M Burnett-Bowie | Robert M Neer | Yuli Zhu | Nicholas Derrico | Benjamin Z Leder | Yuli Zhu
[1] J. Currey. The effect of porosity and mineral content on the Young's modulus of elasticity of compact bone. , 1988, Journal of biomechanics.
[2] Hang Lee,et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial , 2013, The Lancet.
[3] Bert Van Rietbergen,et al. Finite element analysis performed on radius and tibia HR-pQCT images and fragility fractures at all sites in postmenopausal women. , 2010, Bone.
[4] J A McGeough,et al. Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure. , 1993, The Journal of bone and joint surgery. American volume.
[5] Hang Lee,et al. Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. , 2010, The Journal of clinical endocrinology and metabolism.
[6] Sharmila Majumdar,et al. Age- and Gender-Related Differences in the Geometric Properties and Biomechanical Significance of Intracortical Porosity in the Distal Radius and Tibia , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] R. Rizzoli,et al. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis , 2010, Rheumatology International.
[8] H. Macdonald,et al. Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis , 2010, Osteoporosis International.
[9] Wei Wei,et al. Parathyroid Hormone and Mechanical Usage Have a Synergistic Effect in Rat Tibial Diaphyseal Cortical Bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] E. Seeman,et al. A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images. , 2013, Bone.
[11] X. Guo,et al. Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. , 2011, The Journal of clinical endocrinology and metabolism.
[12] X. Guo,et al. Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study. , 2014, The Journal of clinical endocrinology and metabolism.
[13] D. Burr,et al. Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] R. Rizzoli,et al. Risedronate Slows or Partly Reverses Cortical and Trabecular Microarchitectural Deterioration in Postmenopausal Women , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] N Loveridge,et al. Regional differences in cortical porosity in the fractured femoral neck. , 1999, Bone.
[16] E Vicaut,et al. Distribution of Intracortical Porosity in Human Midfemoral Cortex by Age and Gender , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] Toru Hirano,et al. Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] F. Eckstein,et al. Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. , 2002, Bone.
[19] Mary L Bouxsein,et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.
[20] Sharmila Majumdar,et al. Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. , 2010, Bone.
[21] P. Delmas,et al. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial , 2012, Osteoporosis International.
[22] JB. Pialat,et al. Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture. , 2012, Bone.
[23] P. Delmas,et al. Finite element analysis performed on radius and tibia HR‐pQCT images and fragility fractures at all sites in men , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] E. Hauge,et al. Differing effects of PTH 1–34, PTH 1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18‐month open‐labeled observational study using HR‐pQCT , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Sharmila Majumdar,et al. A Longitudinal HR-pQCT Study of Alendronate Treatment in Postmenopausal Women With Low Bone Density: Relations Among Density, Cortical and Trabecular Microarchitecture, Biomechanics, and Bone Turnover , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] O. Johnell,et al. An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women , 2001, Osteoporosis International.
[27] R. Rizzoli,et al. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis , 2011, Osteoporosis International.
[28] Sharmila Majumdar,et al. Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] S. Boonen,et al. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] J. Finkelstein,et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.
[31] Bert Van Rietbergen,et al. Finite Element Analysis Based on In Vivo HR‐pQCT Images of the Distal Radius Is Associated With Wrist Fracture in Postmenopausal Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] 平野 徹. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits , 1999 .
[33] R. Recker,et al. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. , 2007, Bone.
[34] Ego Seeman,et al. Differing effects of denosumab and alendronate on cortical and trabecular bone. , 2014, Bone.